Azzolini, E.; Canziani, L.M.; Voza, A.; Desai, A.; Pepys, J.; De Santis, M.; Ceribelli, A.; Pozzi, C.; Turato, M.; Badalamenti, S.;
et al. Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals. Vaccines 2022, 10, 439.
https://doi.org/10.3390/vaccines10030439
AMA Style
Azzolini E, Canziani LM, Voza A, Desai A, Pepys J, De Santis M, Ceribelli A, Pozzi C, Turato M, Badalamenti S,
et al. Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals. Vaccines. 2022; 10(3):439.
https://doi.org/10.3390/vaccines10030439
Chicago/Turabian Style
Azzolini, Elena, Lorenzo Maria Canziani, Antonio Voza, Antonio Desai, Jack Pepys, Maria De Santis, Angela Ceribelli, Chiara Pozzi, Massimo Turato, Salvatore Badalamenti,
and et al. 2022. "Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals" Vaccines 10, no. 3: 439.
https://doi.org/10.3390/vaccines10030439
APA Style
Azzolini, E., Canziani, L. M., Voza, A., Desai, A., Pepys, J., De Santis, M., Ceribelli, A., Pozzi, C., Turato, M., Badalamenti, S., Germagnoli, L., Mantovani, A., Rescigno, M., & Selmi, C.
(2022). Short-Term Adverse Events and Antibody Response to the BNT162b2 SARS-CoV-2 Vaccine in 4156 Health Care Professionals. Vaccines, 10(3), 439.
https://doi.org/10.3390/vaccines10030439
